Cell Line Development

Cell Line Development in Biologics Production

Efficient screening of mammalian cells to find high-producer clones is a critical step in the antibody production process, particularly in today’s competitive biopharma industry where time is of the essence. Current technologies for finding and cloning high-value cells are often slow and labour-intensive, utilising precious research time and putting a drain on internal resources.

We’ve taken all these common bioprocess challenges into account and developed a unique platform, Cyto-Mine®, that will help you find your highest producers from your large starting cell population and then selectively dispense only those cells of interest. The entire process is faster, circumvents a number of steps required in traditional processes as they are all performed in one instrument and significantly lowers overall costs.

Find Out More About Our Integrated Systems

The Unique Benefits of Our Systems for Biologics Production

Sorting CHO cells for a high antibody expressors is commonly done by cell sorting. While this technology offers high throughput, it can sometimes cause damage to fragile cells. Alternatively, clone pickers can be used, but this method is very low throughput.

Our picodroplet technology is the perfect balance between the two – it’s gentle on cells and can screen at a very high rate of over one million cells per day. As you can see in the graph, using picodroplets for sorting CHO cells results in almost double the cell survival rate when compared to cell sorting. This enables researchers studying antibody producing cells to retrieve more valuable clones and analyse more cells in less time. This increases the chances of finding high producing variants. Lastly, because picodroplets trap secreted antibodies, it offers ultra-sensitive and rapid assays over both cell sorting and clone pickers which can only measure cell-surface associated antibodies or diffused molecules respectively.

Learn More About Our Technology and its Benefits

Our Systems in Action for Antibody Production

Our technology can be applied to antibody production using various cell types, but most customers to date have focused on the use of Chinese Hamster Ovary (CHO) cells – as it is one of the most commonly used mammalian host cell lines utilized for research and bioproduction.
Maintaining high levels of antibody secretion is essential for effective antibody manufacture. To highlight how powerful our systems are for this application, we compared the performance of suspension CHO cells grown in picodroplets alongside those grown in a shake flask.

Initially, the CHO cells were washed and split into two equal proportions, after which they were encapsulated in picodroplets or added to growth media in a shake flask. The cells were then incubated, harvested at hourly intervals and antibody production analyzed (i.e. by measuring IgG concentration).

As can be seen in the graph, the results showed that the cells grown in picodroplets produced more monoclonal antibodies compared to those grown in the flask (likely due to improved gas exchange in the picodroplet format). This was especially true of prolonged culture times, showing that our Cyto-Mine® system can significantly improve the production efficiency and yield when generating antibodies for use in biopharmaceuticals, scientific research or as diagnostic tools.

Application Note: Find out how to streamline Cell Line Development by identifying high-producing clones with monoclonality assurance in one day.

Discover how Cyto-Mine®

  • Identifies high producing clones from a mixed population.
  • Accurately identifies clonality.
  • Significantly shortens the Cell Line Development workflow by using a single fully integrated instrument.

Download Application Note

Other Applications for Cyto-Mine®

Other applications of Cyto-Mine® include:

  • Cancer Research
  • Synthetic Biology
  • Stem Cell Research
  • Single Cell Isolation for next-generation sequencing (NGS)